What are the characteristics of a syphilis rash and how is it treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Characteristics of Syphilis Rash and Treatment

Syphilis rash typically presents as a non-itchy, non-painful maculopapular eruption that prominently involves the palms and soles, and is treated with benzathine penicillin G as the first-line therapy for all stages of infection. 1, 2

Clinical Presentation of Syphilis Rash

Primary Stage

  • Characterized by a solitary, painless chancre at the site of inoculation 2
  • Usually appears 3-4 weeks after infection
  • Heals spontaneously within 3-6 weeks even without treatment

Secondary Stage (Classic Rash)

  • Appears 2-8 weeks after the primary chancre
  • Key characteristics:
    • Diffuse, symmetrical maculopapular rash
    • Classically involves palms and soles (highly distinctive feature) 3
    • Typically non-itchy and non-painful
    • Copper-red or ham-colored lesions
    • May affect the entire body including mucous membranes 4
  • Associated findings:
    • Condyloma lata: raised, fleshy, highly infectious lesions in moist areas 4
    • Generalized lymphadenopathy
    • Systemic symptoms: fever, malaise, headache, sore throat 5

Latent and Tertiary Stages

  • Latent stage: no visible skin manifestations, diagnosed only by serology 2
  • Tertiary stage: may present with gummatous lesions (nodular, ulcerative lesions of the skin and bones) 5

Diagnosis

  • Dark-field microscopy of lesion exudate (if available)
  • Serologic testing:
    • Screening with non-treponemal tests (RPR or VDRL)
    • Confirmation with treponemal-specific tests 2

Treatment Guidelines

First-line Treatment

  • Primary, Secondary, and Early Latent Syphilis (< 1 year duration):

    • Benzathine penicillin G 2.4 million units IM in a single dose 1, 6
  • Late Latent Syphilis or Latent Syphilis of Unknown Duration:

    • Benzathine penicillin G 7.2 million units total, administered as 3 doses of 2.4 million units IM at 1-week intervals 1
  • Neurosyphilis:

    • Penicillin G aqueous 18-24 million units IV daily, administered as 3-4 million units every 4 hours for 10-14 days 1

Alternative Regimens (for non-pregnant, penicillin-allergic patients without neurosyphilis)

  • Doxycycline 100 mg orally twice daily for 14 days (early) or 28 days (late)
  • Tetracycline 500 mg orally four times daily for 14 days (early) or 28 days (late) 1

Special Populations

  • Pregnant women: Penicillin is the only proven effective treatment; desensitization required if allergic 1
  • HIV-infected patients: Same regimens as HIV-negative patients but require closer follow-up 1

Treatment Monitoring

  • Quantitative non-treponemal test titers (RPR or VDRL) should be obtained at baseline
  • Follow-up titers at 6,12, and 24 months after treatment
  • Successful treatment should show a fourfold decline in titers within:
    • 6 months for primary/secondary syphilis
    • 12-24 months for latent/late syphilis 1, 2

Important Considerations

  • Jarisch-Herxheimer reaction: acute febrile reaction with headache and myalgia within 24 hours of treatment, especially common in early syphilis 6
  • Partner notification and treatment is essential:
    • Sexual contacts within 90 days of diagnosis should be treated presumptively even if seronegative
    • Contacts from >90 days should be treated presumptively if follow-up is uncertain 6, 1
  • Treatment failure should be suspected if:
    • Signs or symptoms persist or recur
    • Four-fold increase in non-treponemal test titers
    • Failure of titers to decrease four-fold within expected timeframe 1

Common Pitfalls

  • Misdiagnosis due to varied presentations - always consider syphilis in any unusual rash, especially involving palms and soles
  • Inadequate follow-up after treatment
  • Failure to identify and treat sexual contacts
  • Using macrolides empirically (resistance has emerged) 5
  • Overlooking neurosyphilis, which can occur at any stage and requires CSF examination for diagnosis 2

References

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and management of syphilis.

American family physician, 2003

Research

Secondary Syphilis.

Clinical practice and cases in emergency medicine, 2020

Research

Oral Secondary Syphilis.

Head and neck pathology, 2016

Research

Syphilis: Re-emergence of an old foe.

Microbial cell (Graz, Austria), 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.